#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    HER2 gene amplification Hydrocephalus Endometrial adenocarcinoma Palmoplantar pustulosis Metabolic disorder Follicular lymphoma stage I Chronic myeloid leukaemia Neuroendocrine carcinoma of the skin Acute graft versus host disease in intestine Oropharyngeal cancer recurrent Myxofibrosarcoma Pericarditis Sickle cell disease Sarcoidosis Prophylaxis against transplant rejection More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Diagnostics Soft tissue sarcoma – Life with Disease Basal cell naevus syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Retinitis pigmentosa Epidermolysis bullosa – Diagnostics Gaucher’s disease type I – Life with Disease Mucopolysaccharidosis I – Trials in Disease Haemophagocytic lymphohistiocytosis – Basic Information Ewing’s sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Succinate Estradiol Hemihydrate Mifamurtide Ciclosporin Padeliporfin Ziftomenib Pozelimab Pemigatinib Sodium Acetate Trihydrate VTX-002 Acemetacin Pf-06480605 Naloxone Hydrochloride Propofol Somapacitan Bidridistrogene Xeboparvovec Artemisia Vulgaris Acenocoumarol Aticaprant VOXVOGANAN More therapies…

    Learn about Your Condition

    Supranuclear palsy Torticollis Epilepsy Chronic coronary syndrome Osteonecrosis of jaw Oxygen saturation Tendon injury Aortic disorder Osteochondrodysplasia Bipolar I disorder Peripheral ischaemia Ulcerative keratitis BK virus infection Aortic valve disease Gastrooesophageal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    The Netherlands Poland

  • Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • Everolimus
    • L-Arginine Hydrochloride
    Belgium France Italy Spain

  • Study on the Safety and Effectiveness of IMA402, Tocilizumab, and Human Serum Albumin for Patients with Recurrent or Resistant Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Ima402
    • IMA401
    • Human Serum Albumin
    Germany The Netherlands

  • Study on [68Ga]Ga-PentixaFor PET Imaging for Better Risk and Disease Assessment in Patients with Multiple Myeloma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    Belgium The Netherlands

  • Phase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Bleomycin
    • Brentuximab Vedotin
    • Vinblastine Sulfate
    Belgium Denmark Ireland The Netherlands Portugal Slovakia +1

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Recruiting

    3 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Pigmentary glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1
Previous Page
1 … 595 596 597 598 599 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!